AQST CLO granted stock and options
Aquestive Therapeutics reported that Chief Legal Officer Thomas A. Zalewski received equity-based compensation.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Aquestive Therapeutics reported that Chief Legal Officer Thomas A. Zalewski received equity-based compensation. He was granted 100,000 shares of restricted Common Stock, which will vest in three annual installments of 25%, 25%, and 50%. He also received a Non-Qualified Stock Option for 75,000 shares of Common Stock at an exercise price of $4.135 per share, vesting on the same 25%/25%/50% schedule and expiring in 2036. After these awards, his reported holdings from this grant are 100,000 shares of Common Stock and options for 75,000 underlying shares.
Insider Trade Summary
Grant/Award: 175,000 shares
Grant/Award
2 txns
Insider
Zalewski Thomas A.
Role
Chief Legal Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Non-Qualified Stock Option (right to buy) | 75,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 100,000 | $0.00 | $0.00 |
Holdings After Transaction:
Non-Qualified Stock Option (right to buy) — 75,000 contracts (Direct);
Common Stock — 100,000 shares (Direct)
Footnotes (2)
- F1. The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.
- F2. The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.
Key Figures
Restricted Stock Grant: 100,000 shares
Stock Option Grant: 75,000 options
Option Exercise Price: $4.135 per share
+3 more
6 metrics
Restricted Stock Grant
100,000 shares
Common Stock award to Chief Legal Officer
Stock Option Grant
75,000 options
Non-Qualified Stock Option for Common Stock
Option Exercise Price
$4.135 per share
Strike price for 75,000-share option grant
Common Shares After Grant
100,000 shares
Total Common Stock reported following transaction
Options After Grant
75,000 options
Total options reported following transaction
Option Expiration
2036-05-08
Expiration date of Non-Qualified Stock Option
Key Terms
restricted stock, Non-Qualified Stock Option, vest, exercise price, +1 more
5 terms
restricted stock financial
"The Common Stock is represented by restricted stock which will vest in three annual installments"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
Non-Qualified Stock Option financial
"Non-Qualified Stock Option (right to buy) with an exercise price of 4.1350"
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
vest financial
"will vest in three annual installments with 25% on the 1st, 25% on the 2nd, and 50% on the 3rd installment"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
exercise price financial
"conversion or exercise price of 4.1350 for the Non-Qualified Stock Option"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration date of 2036-05-08 for the Non-Qualified Stock Option grant"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did AQST grant to Chief Legal Officer Thomas Zalewski?
Thomas Zalewski received 100,000 shares of restricted Common Stock and a Non-Qualified Stock Option for 75,000 shares at $4.135 per share, providing both immediate and long-term equity incentives tied to Aquestive Therapeutics’ performance.
How do the new restricted stock awards for AQST’s Chief Legal Officer vest?
The 100,000 restricted shares vest over three annual installments: 25% in the first installment, 25% in the second, and 50% in the third. This multi-year vesting schedule is designed to support long-term retention and alignment with shareholders.
What are the key terms of Thomas Zalewski’s new AQST stock options?
The Non-Qualified Stock Option covers 75,000 shares of Common Stock at a $4.135 exercise price. The options vest 25%, 25%, and 50% over three annual installments and expire in 2036, offering long-dated upside if the share price exceeds the strike.
Is the Form 4 for AQST’s Thomas Zalewski a stock purchase or a grant?
The Form 4 reflects a grant or award acquisition, not an open-market purchase. Zalewski received restricted stock and stock options as part of compensation, with no reported cash paid per share in these transactions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates